Skip to content
Medical Health Aged Care

“Retailers who sell deadly products should pay a price”: Research prompts calls to introduce tobacco retailer licensing fees in NSW

Public Health Association of Australia (NSW) and Australian and New Zealand Journal of Public Health 3 mins read


New research has prompted public health experts to call on the NSW Government to introduce tighter tobacco retail regulation and annual tobacco retailer licence fees to help continue to drive down smoking rates. 


Across the country there are a mishmash of licensing laws applied to retailers wishing to sell tobacco, also with varying fees. In NSW, there is no positive licensing scheme in place with retailers only having to notify Government once if they intend to sell tobacco, with no fees attached. 


A new article published in the Australian and New Zealand Journal of Public Health looks at the impact of significant changes to tobacco licensing introduced in SA in January 2007, when the annual cost of retail tobacco licences rose 15-fold from $12.90 to $200. It builds on prior research that showed that the initial fee increase led to an almost 24 percent decrease in the number of tobacco retailers within two years. 


Co-author Professor Caroline Miller, Director of Health Policy at the South Australia Medical Health Research Institute (SAHMRI), says the latest analysis of what happened in SA between 2009 and 2020 shows large fees are needed to prompt retailers to re-evaluate their selling of tobacco. 


“Since 2007, the fee in SA has only gradually been increased in line with indexation,” Prof Miller says.


“In the latest analysis, we found that the number of licences has continued to fall from 2,707 in 2009 to 1,810 in 2020, a 33 percent decline over 11 years. However, this is only an incremental change. The research suggests significant fee introductions or hikes help prompt retailers to reevaluate being in the unethical business of tobacco.” 


Ms Anita Dessaix, Public Health Association of Australia (PHAA) NSW Spokesperson and Director, Cancer Prevention and Advocacy at Cancer Council NSW says it’s extremely disappointing and concerning that NSW lags behind most other states that have a higher standard of tobacco licensing.


“It’s ridiculous that in NSW retailers only have to notify Government if they are intending to sell tobacco, a product that if used as intended kills, while nearly all other states have licensing schemes with yearly fees attached. 


“Tobacco is still the leading preventable cause of death and disability in NSW, and the social costs of smoking have been estimated at about $8.4billion. In NSW around 6,700 deaths and more than 62,900 hopsitalisations were attributed to smoking. NSW retailers who sell these deadly products get off scot-free, without paying a licensing fee, while people who smoke pay the ultimate price with their health or life.  


“Tobacco is sold in most supermarkets, in corner stores, petrol stations and tobacconists across the state – undermining NSW residents genuine attempts to quit. A positive licensing scheme could instead help fund compliance and enforcement efforts, as well as broader efforts to encourage and support people to quit. 


“While current smoking among across the NSW adult population has steadily declined over the past 20 years and is now sitting at 11.4%, among the most disadvantaged quintile current smoking is significantly higher at 19.4%. 


“To help drive down smoking rates in NSW the Government needs to ask themselves – are we doing all we can? It’s time to put tobacco retailer licensing on the radar.” 


The Public Health Association of Australia is calling on all Governments to adopt a higher standard of licensing laws, including higher licensing fees, across the country to help drive down smoking rates. 

The Federal Government has committed to a target of decreasing smoking rates to below 10% by 2025, and to 5% or less by 2030.The National Tobacco Strategy has a number of actions relating to licensing, including considering restricting or prohibiting the sale of tobacco products in premises where alcohol is consumed, including vending machines; banning or restricting the sale of tobacco online and through smartphone applications; and considering a framework for a national licensing scheme, but these strategies are yet to be funded or implemented. 


For media interviews please contact: 

Hollie Harwood, Strategic Communications Advisor, Public Health Association of Australia,, 0400 762 010 

Paris Lord, Media and Communications Manager, Public Health Association of Australia, 0478 587 917

Note to editors: 

“Is it time to increase the cost of tobacco licences after 10 years of stagnation?” has been published here

Please credit the Australian and New Zealand Journal of Public Health.


All articles are open access and can be found here:


The Australian and New Zealand Journal of Public Health is a publication of the Public Health Association of Australia.





More from this category

  • Medical Health Aged Care
  • 20/04/2024
  • 04:30
Dementia Australia

Join us TODAY for Bendigo Memory Walk & Jog

What: Dementia Australia’sBendigoMemory Walk & Jog When: Saturday 20 April, from 8am Who: More than 390 locals participating on the day. People who have been impacted by dementia, their family, friends and carers. Where: Bendigo Botanic Gardens, Bendigo For more information visit: Walk or jog with us. We are in this together. Dementia Australia is the source of trusted information, education and services for the estimated more than 421,000 Australians living with dementia, and the more than 1.6 million people involved in their care. We advocate for positive change and support vital research. We are here to support people…

  • Contains:
  • Medical Health Aged Care, Science
  • 19/04/2024
  • 15:00
Monash University

Large-scale genetic study finds new link between Irritable Bowel Syndrome and the cardiovascular system

New research published today in the journal Cellular and Molecular Gastroenterology and Hepatology sheds light on disease mechanisms common to irritable bowel syndrome (IBS) and cardiovascular diseases (CVD). Led by Dr Leticia Camargo Tavares, a Postdoctoral Fellow at the Hypertension Research Laboratory within Monash University’s School of Biological Sciences, the study reveals novel insights into the genetic underpinnings of IBS, offering potential avenues for therapeutic intervention. IBS is one of the most prevalent gastrointestinal disorders globally, affecting up to 10 per cent of the population, with a disproportionate impact on women. It is characterised by a complex range of symptoms…

  • Medical Health Aged Care
  • 19/04/2024
  • 11:13
Gilead Sciences Australia

Australian community organisations addressing viral hepatitis receive AU$400,000 via global Gilead ALL4LIVER Grant program

– Gilead Sciences joins forces with World Hepatitis Alliance and experts to drive progress on viral hepatitis elimination targets – – Australian initiatives well represented in Gilead’s US$4 million global fund to empower local communities in the fight against viral hepatitis – Melbourne, Australia, 19 April 2024 – Today, on World Liver Day, Gilead Sciences Australia has announced nine local community organisations addressing viral hepatitis will receive a combined AU$400,000 via the global Gilead ALL4LIVER Grant. The recipients were selected by an independent external review panel of global experts, including the World Hepatitis Alliance. Australia has committed to achieving the…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.